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Abstract 
Polycystic ovary syndrome (PCOS) is an endocrine system disorder that affects women 
of reproductive age.  If not treated properly, PCOS can lead to infertility.  Lack of proper 
treatment of PCOS may also result in medical complications such as diabetes or heart 
disease. The rural clinic where this project took place did not have a mandatory guideline 
for treatment of PCOS; therefore, no standardized method of diagnosis or treatment of 
PCOS existed. The purpose of this project, guided by the IOWA evidence-based practice 
model, was to educate providers on the evidence-based guideline for diagnosis and 
treatment of PCOS outlined by the Endocrine Society Taskforce. The guideline was 
selected after a comprehensive literature review and was used to develop an educational 
program that was provided to 5 nurse practitioners, the medical director and staff.  A pre-
test post-test design was used to determine if the participants understood the content from 
the guideline that was presented. Results showed that the researcher-developed test 
administered to participants yielded scores of 74 on the pre-test and increased after the 
education program with all participants scoring 100 on the post-test. The guideline used 
for the education was then presented to the clinic for implementation with the assistance 
of the medical director’s support. The project provided an evidence-based guideline for 
diagnosing and treating PCOS and raised awareness of PCOS among all staff in a rural 
clinic where many patients with PCOS are treated.  Positive social change may result as 
providers are better prepared to deliver evidence-based care for PCOS and as infertility 
and complications of untreated PCOS are reduced.     
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Section 1: Nature of the Project 
Introduction 
Polycystic ovary syndrome (PCOS) is an endocrine disorder that can affect a 
woman’s ovaries and reproductive system (Mayo Clinic, 2016).  When a woman has 
PCOS and it is not managed appropriately, it can affect her ability to conceive.  The exact 
cause of PCOS is unknown.  Factors that play a role in the development of PCOS include 
excess insulin, low-grade inflammation, and hereditary (Mayo Clinic, 2016).  Scholars 
have compared the recommendation of lifestyle changes (diet/exercise) as opposed to 
treatment with clomiphene and Metformin for infertility (Fica, Alba, Constantin, & 
Dobri, 2008).  Metformin is a drug that is used to treat Type 2 diabetes by improving the 
way that the body handles insulin (Diabetes Self-Management, 2016).  Clomiphene is a 
fertility medicine that affects the pituitary gland (Drugs.Com, 2016). Researchers have 
also examined menstrual patterns and body mass index (BMI) as they relate to increased 
fertility after starting Metformin versus lifestyle modifications only (Curi et al, 2012).  
Curi et al. (2012) showed that menstrual pattern improved in both groups: however, there 
was a significant decrease in BMI in the lifestyle change only group. The implementation 
of mandatory guidelines within a practice may result in improved care and increased 
fertility.  Clinical practice guidelines can improve the quality of care and this has been 
demonstrated by rigorous evaluations.  Clinical practice guidelines are designed as 
recommendations about the care of patients within conditions provided to clinicians (Up-
To-Date, 2016). Their intent is to optimize patient care.  Guidelines have changed focus 
from the effectiveness of interventions to the size of the effect and balance between 
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effects and cost (Up-To-Date, 2016).  The Endocrine Society Task Force (2013) 
developed guidelines to treat PCOS.  These guidelines are not always followed by 
obstetric and gynecology physicians and providers.  The Endocrine Society Task Force 
guidelines first recommended using Rotterdam criteria for diagnosing PCOS (as cited in 
Legro, 2016).  This includes the presence of two of the following criteria: ovulatory 
dysfunction, androgen excess, or polycystic ovaries (Legro, 2016). For women who are 
not trying to conceive, hormonal contraceptives are the first line of management for 
PCOS.  Clomiphene, which is used to induce ovulation, is currently the first-line therapy 
for infertility (Legro, 2016).  Metformin is beneficial, in conjunction to the clomiphene, 
for improving menstrual abnormalities (Legro, 2016).  The recommendation of exercise 
therapy and dietary intention is also found within these guidelines.  The specifics of 
certain diet modifications are addressed in the guidelines. After becoming pregnant 
Metformin is recommended as a first-line treatment for prevention of pregnancy 
complications (Legro, 2016).  
Problem Statement 
Infertility is a problem that many women face. Infertility is considered a disease 
of the reproductive system, and it is defined by failure to achieve clinical pregnancy 
within 12 months of unprotected sexual intercourse (World Health Organization, 2016). 
Women can have infertility problems that start years prior to the diagnosis. They are 
usually not recognized until the couple is trying to conceive.  Infertility issues should be 
addressed, evaluating both the male and female for issues.  PCOS is one of the causes of 
infertility. Most providers will not start evaluating the problem until the woman has been 
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trying to become pregnant for more than 12 months (Sherbahn, 2016).  For women over 
the age of 35, earlier evaluation and treatment may be justified based on medical history 
and physical findings and is warranted after 6 months (Sherbahn, 2016).  Not identifying 
the cause of the problem can delay treatment and the likelihood of becoming pregnant. At 
the age of 35, fertility declines, which makes it even more important for these patients to 
receive proper treatment.  Some women may miss this window of opportunity to 
conceive if the PCOS is not managed properly from the start of diagnosis.  
Purpose Statement 
The purpose of this project was to educate providers with the proper guidelines 
for the treatment for PCOS.  Identification of why it is important to implement these 
proper guidelines was established. I evaluated increased fertility, decreased BMI, and 
decreased insulin levels from an organizational standpoint; however, I also outlined a 
successful planning phase for this organizational. The Endocrine Task Force (2013) 
formulated practice guidelines for the treatment of PCOS; however, providers do not 
usually follow these recommendations.  
Women with PCOS are at higher risk for many health problems.  These health 
problems include pregnancy complications, endometrial cancer, obesity, depression, 
obstructive sleep apnea, fatty liver, Type 2 diabetes, and cardiovascular risk (Legro, 
2016).  Educating providers on the treatment of PCOS may make them more willing to 
follow guidelines when treating these patients.  Providers require skills and knowledge in 
order to provide competent care to protect people using the health care system.  Health 
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care education is one key to ensuring quality of life, improving patient outcomes, and 
protecting individuals from harm (Grimm, 2014). 
Nature of Doctoral Project 
The purpose of this doctoral project was to demonstrate advanced knowledge in 
the area of nursing, research, and evidence-based practice. This project has laid the 
foundation for future scholarship.  This project allowed me to demonstrate my 
achievement of the 8 DNP essentials. I believe that this project is the beginning of many 
scholarly contributions in the future.  The other goal of this project was to reiterate to 
providers the purpose of guidelines and their use.  Guidelines are set in place to guide 
practice although each individual should be addressed as an individual. These guidelines 
are validated through evidence and should be used as much as possible.  
Significance 
Proper treatment for PCOS is a significant problem. PCOS is a prevalent disorder.  
PCOS affects 5-10% of women of childbearing age (20-40) and 30% of women have 
PCOS symptoms (Health Grades, 2014). This age range is a critical part in a woman’s 
life to produce life and have a family.  Proper treatment during this stage, or prior, in a 
women’s life could be the difference between becoming pregnant and not becoming 
pregnant. Providers play a role in the decision-making process for treatment plans for 
these women.  Providers need to make the appropriate recommendations for these women 
based on what evidence has shown.  The infertility rate for women with PCOS is high 
and each additional year or time wasted on improper treatment or lack of diagnosis 
increases these rates. Proper education and proper guideline adherence will lead to proper 
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treatment and increased fertility.  For this project, my focus was on the planning portion 
for provider education and algorithm/guideline use. As the organization continues to 
carry out the project with their patients, they should see an increase in fertility, decrease 
BMI, and decrease insulin levels.  As the BMI and insulin levels decreases, so does the 
risk for the complications of PCOS.  
Summary 
PCOS is a common condition. It is associated with many complications.  Scholars 
have identified different treatment modalities that can provide better outcomes. Having 
clinical guidelines in place can assist medical providers with caring for these patients. 
The problem addressed in this project was the complications that are seen when women 
do not receive proper treatment. The purpose of this project was to educate the providers 
on the use of the Endocrine Task Force guidelines. Statistical data were produced to show 
the significance of this disorder and it prevalence. Implementing the proper guidelines 
will ensure timely treatment as well as improve patient satisfaction. 
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Section 2: Background and Context 
Introduction 
Infertility related to PCOS continues to affect many women in the United States.  
The purpose of this evidence-based practice project was to improve health care delivery.  
In this study I sought to discover the effectiveness of the quality improvement planning 
regarding the adoption of the PCOS practice guidelines/algorithm and the educational 
program. Theories that were used as frameworks for this project were the Lewis Change 
theory as well as the IOWA model. 
Concepts, Models, and Theories 
The use of the IOWA model was beneficial for use in this quality improvement 
project. The focus of the IOWA model is on collaboration and organization incorporating 
conduct and the use of research along with other types of evidence (Doody & Doody, 
2011).  It was introduced in 1994 and is used in research programs and is in nursing 
journals (Doody & Doody, 2011).  This model focuses on problem-focused triggers and 
knowledge that drives staff to begin to question if there is a better way of doing things 
(Doody & Doody, 2011).  The IOWA model is composed of seven steps: selection of a 
topic, forming of a team, evidence retrieval, grading the evidence, developing an 
evidenced-based practice (EBP) standard, implementing the EBP, and evaluation (Doody 
& Doody, 2011).  Each step was implemented during the project.  
 Another theory or model selected to drive this EBP quality improvement project 
of improving healthcare delivery was the Lewis change model.  Lewis change theory 
includes an examination of change as a process with three distinct stages (Mindtools, 
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2017). The Lewis change model was developed in the 1940s by Lewis (Mindtools, 2017).  
The Lewis model has three stages: the unfreeze stage, the change stage, and the refreeze 
stage (Mindtools, 2017).  The first stage is the unfreeze stage. During this stage, the 
organization is prepared to accept that a change is needed (Mindtools, 2017). During the 
unfreezing stage, the existing status quo is broken down in order to build up a new way of 
doing things (Mindtools, 2017). The next step of the Lewis change theory is the change.  
This stage is also called the movement. During the change stage, some of the persons 
involved may have an unsure feeling; however, that unsure feeling begins to resolve in 
the change stage. During the change stage, people begin to support the new direction 
(Mindtool, 2017).  Although the transition is not easy, people start to believe and behave 
in ways that support the new direction (Mindtool, 2017). The last stage of Lewis change 
theory is the refreeze stage.  During this stage, people embrace the new way of doing 
things (Mindtools, 2017). In completing this project, the goal was for the medical 
providers to embrace the new information acquired during education, as well as the 
adoption of the guideline/algorithms. For this project, the change that was needed was for 
women to obtain the proper diagnosis and treatment of PCOS. Proper treatment of PCOS 
can increase fertility rates, improve insulin levels, and lower BMIs.  The goal was met 
with success with the implementation of the guidelines.  
Relevance to Nursing Practice 
Awareness of PCOS has been an ongoing problem. Medical providers do not 
always order the necessary test that aid in making the appropriate diagnosis (Parker, 
2015).  Some medical providers are not aware of its potential consequences including  
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infertility.  When women have PCOS that is undiagnosed or untreated, they may have 
anovulation (not releasing eggs or ovulating) and/or they could have ovaries that contain 
small cystic structures (Sherbahn, 2016).  This is why it is important to diagnose and 
begin treatment with these women. The infertility rate of women with PCOS is high. 
Many will require treatment to aid with pregnancy (Sherbahn, 2016). Women with PCOS 
are also at higher risk for other medical problems.  Some of the other complications 
associated with PCOS include hypertension, high cholesterol, anxiety, depression, sleep 
apnea, heart attack, diabetes, and breast cancer (Mayo Clinic, 2016).  These potential 
complications make this diagnosis and need for change relevant to nursing practice.   
Organizations that attempt to bring awareness to PCOS treatment are not widely 
supported.  These organizations receive only less than 1% of funding (Parker, 2015). 
Limited funding can lead to the condition crossing disciples and falling through the 
cracks.  Educating those providing the care may help them to combat some of these 
complications as well as decrease infertility.  
Local Background and Context 
The practice setting for this project was a rural outpatient clinic whose patient 
population varied.  This office has patients with a wide range of ages as well as a variety 
of races. Patients are seen at the project site as gynecological patients and may receive the 
diagnosis of PCOS.  Providers can implement the recommended treatment plan per the 
developed guidelines/algorithm.  On a national level, many women are affected by 
PCOS.  It is imperative to establish more of a mandatory guide as well as to educate 
providers caring for these patients. The Endocrine Society Task Force has established 
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diagnostic criteria, as well as treatment guidelines.  Many studies have been performed 
on treatment of PCOS.  According to Pamela Montplaisir (2011), the medication 
Metformin can be used in women with PCOS to help induce ovulation although its 
primary use is for the treatment of Type 2 diabetes. Metformin can increase the 
functionality of the ovaries as well as improve insulin sensitivity (Kurzthaler & 
Hadziomerovic-Pekic, 2015). Many women who would like to become pregnant, but 
have PCOS, are placed on Metformin to help with fertility; however, scholars also show 
that weight loss, even modest weight loss has proven to be an efficient method to 
improve reproductive parameters in PCOS patients (Fica, Albu, Constantin, & Dobri, 
2008). Practitioners can use evidence-based guidelines to ameliorate the quality of care of 
patients by adhering to interventions of proven benefit, while discouraging interventions 
that are not effective (Limb et al, 2016).   
Role of DNP Student 
My role as a DNP student in this project was to first prove the need.  Again, 
clinical practice guidelines should be followed when treating patients.  This ensures that 
the patients are receiving optimum care.  The nurse practitioners in this practice had the 
choice of using guidelines or their own treatment plan.  I was able to prove the need for 
the use of the guidelines. I was also able to provide the educational materials.  I 
developed all of the test and surveys as well as held the meetings with stakeholders.  I 
was able to prove to the medical director that this need existed based on the evidence 
provided. 
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Role of Project Team 
The project team for this EBP quality improvement project consisted of an 
educator, chief executive officer (CEO), office manager, and medical providers for the 
student portion.  The project teams that will continue to carry out the project for the 
organization consist of consenting patients, medical providers, and nurses.  Each person 
involved on the project team will play a role in this project.  The medical providers will 
be treating the patients with PCOS and following the guideline/algorithm.  I designed the 
guideline/algorithm based on EBP.  The educator taught the class that discusses PCOS in 
detail to the providers who will be treating the patients.  The educator also discussed the 
guideline/algorithm that will be used. The patients will be those who consent to be a part 
of this project. The nurses will be collecting the data needed for this project.  The nurses 
will document all of the information gathered and continue for 1-year post 
implementation. The project will take place over the course of a year; however, my 
project extended only through the planning phase.  
Summary 
PCOS diagnosis and treatment is relevant in the medical community. In this 
project I used models and theories such as the IOWA model and Lewis change theory for 
its implementation.  In order to improve outcomes for this condition, the project team was 
selected to carry out this project. After its completion in 1 year we should see an 
improvement in health as well as increased fertility in these women. After the completion 
of my portion it was determined that the project was a well-planned project on current 
healthcare practice within this organization. It included proper planning for the meetings, 
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synthesis of evidence, national guideline review, cost benefit investigation/analysis, and 
stakeholder satisfaction. 
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Section 3: Collection and Analysis of Evidence 
Introduction 
Undiagnosed PCOS and improper treatment continues to be an ongoing problem.  
Because PCOS can lead to infertility as well as other serious medical conditions, 
educating providers, as well as creating a policy for them to follow is important. Women 
with PCOS are at high risk of long-term complications (Terrie, 2004). In this project I 
sought to address this issue through education and guidelines.  Tools from the literature 
were used as well as recommendations from the Endocrine Society Task Force to guide 
this project.  The purpose of this section is to discuss the collection as well as the analysis 
of the evidence for this project. In this section, I will address the practice focused 
questions for this project.  I will also explain the sources of evidence gathered from the 
literature.  In the last section I will discuss the analysis and synthesis process in detail.  
Practiced-Focused Questions 
The purpose of this EBP project was to improve healthcare delivery. The overall 
quality improvement EBP project was multifaceted and complex, and it will continue to 
require a long-term commitment from the organization. The practice-focused questions 
were separated below to outline the umbrella plan for the organization and the portion of 
that plan that I addressed within the time-constraints of this doctoral program. 
Organizational Standpoint: Longview 
This practice question is at the organizational level, is comprehensive, and shows 
the larger picture of this project that went beyond the scope of my work.  
Among females aged 18-45 years old with BMIs >30, an infertility diagnosis, and 
13 
 
seeking care in a rural area clinic in Eastern United States, how does the adoption of a 
Polycystic Ovary Syndrome (POS) practice guideline/algorithm and an educational 
program for providers, per the POS Diagnosis and Treatment Guidelines (per the 
Endocrine Society Task Force http://press.endocrine.org/doi/abs/10.1210/jc.2013-
2350) including medication and/or lifestyle change interventions, impact fertility rates, 
BMI levels, and insulin levels as measured 1 year post implementation compared to 
current practice of providers choosing their own treatment plan. 
My Standpoint: Short view 
The DNP practice question is specific to the planning phase for the aforementioned 
broad, organization-wide project. 
 Among females aged 18-45 years old with BMIs >30, an infertility diagnosis, and 
seeking care in a rural area clinic in Eastern United States, how effective was the quality 
improvement planning regarding the adoption of the POS practice guideline/algorithm 
and an educational program for providers, per the POS Diagnosis and Treatment 
Guidelines (per the Endocrine Society Task 
Force http://press.endocrine.org/doi/abs/10.1210/jc.2013-2350) as measured by the end 
of the DNP program based on the following    
Formative outcomes achievements (e.g. evaluation of current healthcare 
practice within the organization, initiation of stakeholder meetings, synthesis and 
leveling of evidence, national clinical guideline reviews (Endocrine Society Task 
Force), agency policy analysis, development of draft agency-specific evidence-
based guidelines, stakeholder content validity index evaluations of policy/practice 
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change recommendations, expert content review of education materials created, 
secondary analysis of existing agency data on the problem, cost-benefit 
investigation) 
Summative outcomes achievements (e.g., final cost-benefit analysis, 
recommended solutions including final agency policy revision proposal, final 
health care professional education module, pre-post implementation outcome 
measurement strategy, stakeholder satisfaction with DNP project leadership)  
Sources of Evidence 
Clinical practice guidelines are used to improved quality care while reducing 
healthcare cost (Keffer, 2001).  There are over 800 publications of guidelines for medical 
providers (Keffer, 2001).  Although it may be difficult to keep up with the number of 
guidelines that are in place, they still play a role in the guidance of patient care.  In 
contrast to guidelines, algorithms help to simplify things. Guidelines are set in place to 
help guide the medical provider in their decision making for treatment plans; however, 
they are not in place to take away the need to individualize the care of patients.  This is 
often seen with other chronic diseases such as diabetes and hypertension.  The Eighth 
Joint National Committee (JNC 8) guidelines are in place to help the provider in the 
management of hypertension; most health care providers follow it.  The American 
Association of Clinical Endocrinologist (AACE) guidelines are in place for diabetes 
management. Most medical providers also follow it.   
The problem with PCOS treatment is that many medical providers are not familiar 
with the proper diagnosis criteria or the treatment (Parker, 2015).  Some medical 
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providers are not aware that there are also guidelines in place for the diagnosing, 
management, and treatment of PCOS.  The Endocrine Society Task Force has produced 
guidelines to help providers treat women with this diagnosis. However, guidelines are 
inconsistently implemented and used (American College of Surgeons, 2006).  For women 
with PCOs this is a problem.  The time between a woman being diagnosed and treated 
can be the difference between if the women will be able to conceive or not. Medical 
providers can use of a guideline/algorithms and measure key markers such as BMI, 
insulin levels, and number of positive pregnancies when diagnosing and treating PCOS.   
Participates 
The evidence generated for this project was done so strategically.  The 
participants have to meet several qualifying criteria.  They must be female.  They must be 
between the ages of 18-45.  They must have the diagnosis of PCOS as well as a diagnosis 
of infertility.  Their BMI must be greater than 30. These criteria will make this selection 
of participates relevant to the practice-focused questions for the organizational long view. 
The selection process for participates will be carried out by the organization and are 
beyond my duties. I focused on the persons involved in the planning for this project.  This 
included stakeholders such as the CEO, medical director, and office manager of the 
practice.  I looked to obtain buy-in for the project and the willingness for them to carry it 
out to completion after the planning phase.  
Procedures 
 I met with the CEO, medical director, and office manager to discuss this project.  
I discussed the need for the project and explained the algorithm/guideline.  Statistics were 
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shared regarding PCOS, complications, its relation to infertility, and the need to follow 
these guidelines.  After establishing the need as well as the stakeholders being in 
agreement with the project, I presented the algorithm and educational material.  I also 
discussed the costs associated with the project as well as the role that the organization 
will play in carrying out the project once my planning portion was complete.  The 
medical providers, who will care for the patients, participated in a 30-minute educational 
session.  During this session the providers were educated/reviewed the diagnosis and 
treatment of PCOS.  The recommend guidelines per the Endocrine Society Task Force as 
well as the algorithm that will be followed were also discussed. The organization will 
carry out the rest of the steps that will include the selection of participates. They will be 
selected based on the criteria previously discussed as well as them giving informed 
consents.  Participates will have baseline laboratory blood work collected and measured 
prior to the initiation of any treatment. During the visits, the medical provider will initiate 
the treatment as recommended per the guidelines/algorithm while taking each individual 
patient into consideration. The women will come in monthly over the next year to have 
key indicators measured.  During these visits, modifications to therapy can also be made 
and documented.  Also, participates will have a pregnancy test done monthly. The 
treatment for each patient will be documented. 
Protections 
 Procedures that will be used to ensure the ethical protection of the participates 
include the Health Insurance Portability and Accountability Act (HIPPA) standards.  
These standards are followed daily in this doctor’s office and will remain in place for this 
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project.  All participates will have to fill out a consent from to participate in this project. 
One strategy for recruiting participates would be to offer free treatment as well as 
laboratory testing during the course of the project.  This was discussed with the 
stakeholders and will be carried out by them.  I am not responsible for engaging in any 
patient care/data collection nor am I responsible for that portion of the project. I was only 
involved in meeting with the stakeholders and the planning portion of the project.  The 
organization will carry out the project and collect the data. The Institutional Review 
Board  (IRB) played a role in ensuring that the projects remained ethical. The IRB is 
responsible for making sure that research from Walden University complies with U.S. 
federal regulations as well as the university's ethical standards (Walden University 
Centers for Research Quality, 2017).  
Analysis and Synthesis 
 The systems used for recording the data will include the electronic medical 
systems known as Success and another named Orchard.  Success has the capability to 
store the participates monthly visits. The visit documentation will include the vital signs 
with the BMI, the medication list, and any symptoms reported by the patient. The 
Orchard system contains all of the laboratory data.  It has the capability of displaying 
individual data as well as trends.  These data will be analyzed in order to show an 
improvement in PCOS when clinical guidelines are followed.  For my portion of the 
project, the pre and posttest results were used for analysis. 
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Summary 
 Addressing the practice-focused questions and implementing the planning portion 
for this project was not easy, but having a plan in place helped with the process.  Prior to 
implementing the project, the literature was reviewed on the benefits of using clinical 
practice guidelines and algorithms. This information was presented to the stakeholders. 
The method used ensured the validity of the results that were produced.  The selection 
process for participates was selective in order to meet the criteria needed for the practice -
focused questions.  The participates will have to give consent to be apart of the study 
with free treatment offered in returned from their participation.  They are protected by 
HIPPA as well as the IRB. The selected tools used such as the Success and Orchard 
systems have been evaluated and proven to be effective for collecting and reporting data. 
I will only be involved in the planning stage of this project. 
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Section 4:  Findings and Recommendations 
Introduction 
The improper diagnosis and treatment of PCOS can lead to many complications.  
One of these complications includes infertility. According to statistics, 50% of women 
with PCOS go undiagnosed (Health Grades, 2014).  Health Grades (2014) also showed 
that 50% of women with PCOS will develop pre diabetes by the age of 44.  This quality 
improvement EBP was multifaceted and complex and it continues to require a long-term 
commitment from the organization.  I explored the effect of the adaption of a PCOS 
practice guideline/algorithm and education program.  I was focused on the planning 
phase of the project.  The purpose of this project was to educate providers with the proper 
guidelines for treatment of PCOS, identify why it is important to implement these 
guidelines, and increase patient fertility while decreasing complications.  Clinical 
guidelines aim to achieve improved quality care while reducing healthcare cost (Keffer, 
2001).  These guidelines play a role in the guidance of patient care.  Using a simple 
questionnaire form of analysis, it was determined that more education was needed on 
PCOS diagnosis and treatment.  This further supported the need for the 
algorithm/guideline use.  
Findings and Implications 
 The pre education questionnaire consisted of questions taken from the Endocrine 
Society Task Force Guidelines. These guidelines are the gold standard for diagnosing and 
treating PCOS.  The make-up of the questions was focused on proper diagnosis and 
treatment of PCOS. The questionnaire consisted of 10 questions.  These questions ranged 
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from multiple choice, fill in the blank, and true/false type questions. I created and 
administered the pre education questionnaire to five nurse practitioners in the practice 
prior to the education sessions.  The average score on the questionnaires came back at 
74%.  The lowest score on the pre questionnaire was a 60% and the highest score was a 
90% (Appendix D). These findings further supported the need for education and 
guidelines when diagnosing and treating PCOS.  The medical director then led an 
education session, which I developed. Persons present at the education session included 
the nurse practitioners, as well as the other medical staff. The session included a 
discussion of diagnosis and treatment of PCOS, as well as the guidelines/algorithm that 
should be followed when a patient is diagnosed with PCOS per the Endocrine Society 
Task Force. Nurses, certified nursing assistances, and medical assistants also took part in 
the education session. After the nurse practitioners attended the education session, they 
were retested.  All of the nurse practitioners scored a perfect score (100%) and agreed 
that the use of the guideline/algorithm would provide better outcomes for the patients 
(Appendix D).  
The nurse practitioners also agreed that its use would make them feel more 
comfortable when diagnosing and treating these patients.  The medical director of this 
facility agreed to carry out the remainder of the project in his organization with policy 
change at its completion. The remainder of the project will include implementing the 
guidelines as discussed previously.  The patients will come in monthly for testing and the 
trends will be recorded. This will then support the need for the policy change.   
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Based on discussion with the medical director, office manager, and other 
stakeholders, I gained buy-in on the need for the policy change.  The field of nursing has 
many different levels. I focused more on the nurse practitioner level and advancing 
nursing as a whole through education and use of the clinical guidelines.  Guidelines are 
readily available for nurses to use; however they are not always followed. When it comes 
to topics such as PCOS, due to the lack of knowledge, nurse practitioners and other 
providers need policies that mandate their use.  
One limitation that could have impacted the findings was the years of experience 
of the nurse practitioners.  Three out of five nurse practitioners had less than 3 years of 
practice experience.  This could have decreased the scores due to the lack of experience.  
Although this may have been a limitation, this could confirm that the need here is even 
greater.  Implications resulting from these findings include individual and organizational 
use of the guidelines, nurse practitioner growth and improvement in confidence when 
treating PCOS, and educational growth for ancillary staff.  This will benefit the patients 
and the community.  The continuation of this study could provide more data to support 
the need for a change and the initiation of a policy. It could help to display concrete 
evidence that shows a decrease in BMI, decrease in insulin levels, and increases in 
fertility.  These positive implications can be a great change in the rural area. 
Recommendations 
 A recommended solution to the lack of knowledge of diagnosis and treatment of 
PCOS would be the use of the guidelines/algorithm developed from the Endocrine 
Society Task Force (Appendix C).  Healthcare education is one key to ensuring quality of 
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life, improving patient outcomes, and protecting individuals from harm (Grimm, 2014).  
Clinical practice guidelines aim to achieve improved quality care, while reducing 
healthcare (Keffer, 2001).  Following the guidelines provided and implementing this as a 
policy, after the completion of the study, would ensure that providers are ordering the 
necessary test.  This would aid in them in making the appropriate diagnosis and treatment 
plans.  As providers implement the use of the guidelines, if anything falls outside of the 
guidelines, the provider will still have the option of referring directly to the Endocrine 
Society Task Force recommendations  
Strengths and Limitations of the Project 
Strengths 
 One of the strengths of this project was that the topic gained the interest of the 
doctor, nurse practitioners, and other nursing staff.  They were all willing to participate in 
the questionnaires and education session.   Another strength of this project was the 
accessibility of the CEO, medical director, and staff.  This allowed the project to flow 
smoothly due to their accessibility and ease to work with.  Comments from the nurse 
practitioners and medical director indicated the need for this project due to the statistics 
surrounding the diagnosis. 
Limitations 
 One limitation of this project was the small sample size of doctors and nurse 
practitioners who participated.  This practice only has one doctor, five nurse practitioners, 
one nurse, one certified nursing assistant, and two medical assistances.  Another 
limitation of this project was that some of the nurse practitioners had less than 3 years of 
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experience.  Not having as much experience with patients with PCOS could have been 
reflected in the pre education questionnaire scores. 
Future Recommendations 
 There are some recommendations that could be made for future projects 
addressing similar topics and using similar methods. One recommendation would be to 
implement this project at a larger practice. I would also recommend limiting the 
questionnaires to the providers including doctors and nurse practitioners with at least 5 
years of experience.   
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Section 5:  Dissemination Plan 
 Dissemination is an important part of this entire project.  It must be performed in 
a proper manner.  Two of the key reasons for disseminating are to share the information 
with others in the community and to present the information to stakeholders and the 
academic community (Zaccagnini & White, 2011).  The method of dissemination will be 
a presentation by using Power Point software and talking through the presentation or a 
poster board presentation. I will be present the reason for the study, the data collected 
from the nurse practitioners and the scores from the questionnaires.  The guidelines taken 
from the recommendations of the Endocrine Society Task Force will be reiterated.  Due 
to the nature of the product, the audience who would be appropriate for dissemination 
would be nurse practitioners and nurses who diagnose and treat patients with PCOS. 
Nurse practitioners who work in obstetrics, gynecology, and family medicine would 
benefit the most from this dissemination.  To help broaden the nursing profession, 
vendors could include continuing education conferences and even visits to offices that 
could provide a conference room. 
 Another idea for dissemination includes writing an article for publication in a 
nursing journal. This would allow for more nurses and nurse practitioners to have access 
to the information.  Publication could be a useful and effective way of disseminating 
information to audiences who match the needs (Zaccagnini & White, 2011).   
Analysis of Self 
 Over the course of this project I had the sole responsibility of ensuring that the 
project first identified a problem, displayed a gap in practice, gathered data on the topic, 
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and implemented a project, which supported the idea that this problem must be 
addressed.  The development, implementation, and analysis provided me a learning 
opportunity.  I have had leadership roles and opportunities in my health career; however 
this project supported my growth towards thinking as a scholar.  The American 
Association of Colleges of Nursing (AACN) Essentials discusses the DNP- prepared 
nurses role in the scientific underpinnings of nursing practice. It discusses the wide array 
of knowledge that the DNP prepared nurse has and the ability to translate that knowledge 
quickly and effectively (AANP, 2006). AANP also addresses research and EBP (AANP, 
2006).  
This project encouraged me to become a better nurse practitioner, scholar, and 
project manager. As a nurse practitioner I was made more aware of the importance of 
following guidelines when appropriate.  Each clinical experience allowed me to gain 
insight from other leaders and scholars.  This not only allowed me to see how things were 
done, but also increased my confidence in myself.  I started to gain the confidence and 
belief in myself that I could actually complete this challenging project.  As I progressed, I 
gained enough confidence to speak with those in prestigious positions.  I was able to 
speak with the CEO, medical director, office manager, and providers at a facility.  I had 
support from my clinical preceptor, chair, and committee members, which helped 
strengthen this project.  One of my professional goals is to also become an instructor in a 
DNP program.  I can only hope to be as supportive and encouraging to upcoming 
doctoral of nursing students as everyone has been to me.  
Challenges 
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 Challenges were present during the course of this project.  This is usually the case 
with any large project.  One thing that I found challenging was locating a facility that 
would allow me to implement my project.  Many facilities did not want to take on the 
additional responsibility of having a student come in and implement a project.  Another 
challenge that I encountered was trying to find the time to work on my project 
simultaneously with other didactic assignments.  It became necessary to schedule time 
specifically for my project.  Despite the challenges that presented, I was able to overcome 
them. 
Solutions 
 The challenge of locating a facility was a difficult one; however, I was able to 
overcome this challenge by meeting with the CEO of a facility.  After hearing my plans 
he approved.  He as well as his office manager was both impressed and were immediately 
ready to move forward.  As mentioned previously, to solve my time management 
problem, I found that I had to schedule time just to work on my project with no 
distractions. 
Insight 
 There was much insight gained throughout this entire process.  One insight that I 
gained was the ability to carry out a quality improvement project from start to finish.  I 
also gained insight on data collection and analysis.  I gained a large amount of patience 
during this process.  I also learned how to manage disappointment by using it as fuel to 
work harder. 
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Summary 
 PCOS is a disorder affecting many women of reproductive age (Health Grades, 
2014).  When left untreated women are at high risk for complications, which includes 
infertility (Health Grades, 2014).  Clinical practice guidelines are in place to optimize 
patient care; however they are not always followed (Up-To-Date, 2016).  Some providers 
are not aware that recommended guidelines exist as they apply to the diagnosis and 
treatment of PCOS.  When it comes to the prevention of the complications and increasing 
fertility in these women, the use of these guidelines could be what makes the biggest 
difference in their outcome.   
 A group of providers were evaluated, educated, and then reevaluated on their 
knowledge of PCOS diagnosis and treatment.  They were then given an education session 
on the topics.  The providers were given education material as well as the guidelines.  
They were then reevaluated on the diagnosis and treatment of PCOS with the same tool 
used prior.  I found that providers did not know as much as they originally thought 
regarding the topic, which confirmed the need to implement these guidelines into policy 
after the facility carries out the remainder of their portion of the project.  This includes 
the selection of patients, implementation of the guidelines, and collecting patient trends 
on identified values over the course of a year.  The providers as well as the CEO, medical 
director, and office manager were provided a satisfaction survey.  It was used to 
determine if I developed effective quality improvement planning regarding the adaption 
of the PCOS guidelines and an educational program for the providers.  The selected 
persons completing the survey were to take things such as the synthesis and leveling of 
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evidence into consideration.  This EBP quality improvement project has the potential to 
positively influence nursing practice and improve overall outcomes for patients with 
PCOS. 
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Appendix A:  Pre and Post Test Given 
 
TEST	  
 
Polycystic	  Ovary	  Syndrome	  (Take	  the	  same	  test	  after	  reading	  material)	  
 
 
1) What is the name of the criteria used to diagnose PCOS? 
A. DSM-5 
B. SAS  
C. PHQ-9 
D. Rotterdam 
 
 
 
2) Name one clinical manifestation used for the diagnosis of PCOS in 
adolescent girls. _________________________	  
 
3) What are some possible complications of PCOS? 
A. Increased fertility, hyperlipidemia, hypertension, insulin resistance 
B. decreased fertility, obesity, obstructive sleep apnea, endometrial cancer 
C. weightloss, flushing, abnormal uterine bleeding, insulin resistance 
D. obesity, abnormal uterine bleeding, increased fertility, insulin resistance 
 
 
4) Women with PCOS do NOT have a higher cardiovascular risk than 
women without PCOS? 
A. True 
B. False 
 
5) Which symptoms are clinical manifestations of hyperandrogenism? 
Mark all that apply 
A. Alopecia 
B. Acne 
C. Heat intolerance 
D. Hirsutism 
E. Weightloss 
F. Flushing 
 
6) What is the first line treatment therapy for management of PCOS in 
women with out acne, not trying to conceive? 
A. Metformin 
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B. Clomid 
C. Lifestyle modifications (diet/exercise) 
D. Letrozole 
 
7) What is the first line treatment therapy for management of PCOS in 
women with menstrual abnormalities and hirsutism/acne, who are not 
trying to conceive? 
A. Metformin 
B. Hormonal Contraceptives 
C. Lifestyle modifications (diet/exercise) 
D. Clomid 
 
8) What should be the next treatment therapy ordered for management of 
PCOS in women with T2DM or IGT who fail lifestyle modifications? 
A. Fasting 
B. Insulin 
C. Metformin 
D. Low carbohydrate diet 
 
9) What combination therapy can be used to in women with PCOS to 
increase fertility and prevent ovarian hyperstimulation syndrome? 
A. Metformin and Clomid 
B. Metformin and Insulin 
C. Metformin and rosiglitazone 
D. Insulin and pioglitazone 
 
 
10) PCOS is estimated to be the most common cause of anovulatory 
dysfunction. 
A. True 
B. False  
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Appendix B: Satisfaction Survey 
 
Satisfaction	  Survey	  
Please	  answer	  yes	  or	  no	  to	  each	  question.	  
 
 
 
1.)	  The	  student	  DID	  display	  effective	  quality	  improvement	  planning	  regarding	  
the	  need	  for	  the	  adoption	  of	  the	  PCOS	  practice	  guideline/algorithm?	  	  	  	  Yes	  or	  
No	  
 
 
 
2.)	  The	  student	  provided	  expert	  educational	  material	  that	  was	  clear	  and	  
concise?	  	  Yes	  or	  No	  
 
 
3.)	  The	  student	  was	  professional	  and	  displayed	  adequate	  organizational	  and	  
leadership	  skills.	  Yes	  or	  No	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Appendix C:  Guidelines 
 
Educational	  Material	  and	  Guidelines	  
 What	  are	  common	  signs	  and	  symptoms	  of	  polycystic	  ovary	  syndrome	  (PCOS)?	  Common	  PCOS	  signs	  and	  symptoms	  include	  the	  following:	  
• Irregular menstrual periods 
• Infertility—PCOS is one of the most common causes of female infertility. 
• Obesity—Up to 80% of women with PCOS are obese. 
• Excess hair growth on the face, chest, abdomen, or upper thighs—This condition, 
called hirsutism, affects more than 70% of women with PCOS. 
• Severe acne or acne that occurs after adolescence and does not respond to usual 
treatments 
• Oily skin 
• Patches of thickened, velvety, darkened skin called acanthosis nigricans 
• Multiple small cysts on the ovaries What	  causes	  PCOS?	  Although	  the	  cause	  of	  PCOS	  is	  not	  known,	  it	  appears	  that	  PCOS	  may	  be	  related	  to	  many	  different	  factors	  working	  together.	  These	  factors	  include	  insulin	  resistance,	  increased	  levels	  of	  hormones	  called	  androgens,	  and	  an	  irregular	  menstrual	  cycle.	  
 
PCOS	  Complications	  Include	  
 
• Infertility 
• Obesity 
• Obstructive sleep apnea 
• Hypertension 
• Diabetes 
• Endometrial hyperplasia/cancer 
• Fatty Liver Disease 
• Mood disturbances and depression 
• Hyperlipidemia 
 
Diagnosis	  Criteria	  
 The	  most	  common	  diagnostic	  criteria	  used	  are	  Rotterdam	  criteria.	  Patient	  needs	  2	  out	  of	  3	  
 
• Oligo or anovulation 
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• Clinical and/or biochemical signs of hyperandrogenism (hirsutism, acne, 
alopecia). 
• Transvaginal ultrasonographic polycystic ovaries and exclusion of other 
etiologies. 
 
Work-­‐Up	  
 Screening	  workup	  should	  include	  hcg,	  TSH,	  prolactin,	  FSH,	  DHEAS,	  17-­‐OH	  progesterone,	  and	  testosterone	  level.	  	  LH	  determination	  may	  be	  ordered	  but	  is	  not	  necessary.	  Keep	  in	  mind	  that	  drugs	  that	  can	  alter	  results	  include	  (oral	  contraceptives,	  Steroids,	  and	  antidepressants).	  	  Consider	  fasting	  serum	  glucose,	  insulin	  level,	  and	  plasminogen	  activator	  inhibitor-­‐1	  determinations	  to	  establish	  presence	  of	  insulin	  resistance	  and	  glucose	  intolerance.	  
 
Treatment	  of	  PCOS	  
 Lifestyle	  modifications	  such	  as	  weight	  loss	  and	  increased	  exercise	  in	  conjunction	  with	  a	  change	  in	  diet	  consistently	  reduce	  the	  risk	  of	  diabetes.	  This	  approach	  has	  been	  found	  to	  be	  comparable	  to	  or	  better	  than	  treatment	  with	  medication	  and	  should	  therefore	  be	  considered	  first-­‐line	  treatment	  in	  managing	  women	  with	  polycystic	  ovarian	  syndrome	  (PCOS).	  
 The	  Endocrine	  Society	  Task	  Force	  recommends	  HCs	  (i.e.,	  oral	  contraceptives,	  patch,	  or	  vaginal	  ring)	  as	  first-­‐line	  management	  for	  the	  menstrual	  abnormalities	  and	  hirsutism/acne	  of	  PCOS,	  which	  treat	  these	  two	  problems	  concurrently. 
 The	  Endocrine	  Society	  Task	  Force	  suggest	  against	  the	  use	  of	  metformin	  as	  a	  first-­‐line	  treatment	  of	  cutaneous	  manifestations,	  for	  prevention	  of	  pregnancy	  complications,	  or	  for	  the	  treatment	  of	  obesity;	  however,	  they	  do	  recommend	  metformin	  as	  in	  women	  with	  PCOS	  who	  have	  T2DM	  or	  IGT	  who	  fail	  lifestyle	  modification.	  For	  women	  with	  PCOS	  with	  menstrual	  irregularity	  who	  cannot	  take	  or	  do	  not	  tolerate	  HCs,	  we	  suggest	  metformin	  as	  second-­‐line	  therapy.	  
 The	  Endocrine	  Society	  Task	  Force	  recommends	  clomiphene	  citrate	  (or	  comparable	  estrogen	  modulators	  such	  as	  letrozole)	  as	  the	  first-­‐line	  treatment	  of	  anovulatory	  infertility	  in	  women	  with	  PCOS.	  	  	  We	  suggest	  the	  use	  of	  metformin	  as	  an	  adjuvant	  therapy	  for	  infertility	  to	  prevent	  ovarian	  hyperstimulation	  syndrome	  (OHSS)	  in	  women	  with	  PCOS	  undergoing	  in	  vitro	  fertilization.	  
Use	  of	  other	  drugs	  	  We	  recommend	  against	  the	  use	  of	  insulin	  sensitizers,	  such	  as	  inositols	  (due	  to	  lack	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of	  benefit)	  or	  thiazolidinediones	  (given	  safety	  concerns),	  for	  the	  treatment	  of	  PCOS.	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Appendix D:  Test Results 
Pre and Post Test Scores 
  Nurse 1         Nurse   2        Nurse  3        Nurse 4         Nurse   5     Average  
 
Pre             80%               70%               90%               70%               60%               74% 
# Missed     2                     3                     1                     3                     4 
 
Post             100%             100%             100%             100%             100%             100% 
# Missed     0                     0                     0                     0                     0 
 
This data displays the test scores achieved by each of the 5 nurse practitioners. Scores 
ranged from 60% to 90% prior to the education session.  The post scores display a perfect 
score of (100%) for all of the nurse practitioners.  
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Appendix E:  Dissemination Poster  
 
 
 
